Spyre Therapeutics, Inc. (SYRE)
74.05
-0.27
(-0.36%)
USD |
NASDAQ |
May 22, 16:00
73.15
-0.90
(-1.22%)
After-Hours: 20:00
Spyre Therapeutics EPS Diluted (Quarterly) : -0.8785 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.6366 |
| Cogent Biosciences, Inc. | -0.60 |
| Revolution Medicines, Inc. | -2.291 |
| Apellis Pharmaceuticals, Inc. | 0.142 |
| Replimune Group, Inc. | -0.7694 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.00M |
| Total Expenses (Quarterly) | 69.00M |
| Enterprise Value | 5.845B |
| Earnings Yield | -3.18% |
| Normalized Earnings Yield | -3.272 |